| Literature DB >> 35368944 |
Xin Yi1,2, Jong Hak Lee1,3, Xiaogui Yu4, Guoliang Yi5, Ho Seong Lee1,3.
Abstract
Total hip arthroplasty (THA) and total knee arthroplasty (TKA) are effective methods for the treatment of end-stage osteoarthritis. Furthermore, rehabilitation training and psychological interventions play significant roles in the recovery of hip and knee joint function after THA and TKA. A total of 46 patients who received hip replacement and knee replacement are equally divided into two groups, with the control group being prescribed routine rehabilitation intervention and the observation group prescribed an early rehabilitation pathway with Morita therapy intervention. According to the results, the observation group displayed a significantly decreased incidence of deep venous thrombosis, while simultaneously reducing the recovery time of lower limb function (P < 0.05), including straight leg raising time, walking time, and vertical knee flexion time. In addition, the treatment program demonstrates a significant ability to improve the joint function score, pain score, quality of life score, and range of motion score (P < 0.05). Moreover, serum D-dimer, fibrin degradation products (FDP), and femoral vein blood flow peak also are significantly reduced (P < 0.05). Therefore, we have determined that an early rehabilitation pathway combined with Morita therapy can effectively reduce stress pain, improve the recovery process of joint motor function, and reduce the incidence of thrombosis. However, an increased sample size would facilitate the confirmation of the safety and efficacy of the program. In addition, the overall financial expenditure and feasibility of the treatment need to be considered.Entities:
Mesh:
Year: 2022 PMID: 35368944 PMCID: PMC8970862 DOI: 10.1155/2022/4285197
Source DB: PubMed Journal: J Healthc Eng ISSN: 2040-2295 Impact factor: 2.682
Demographic data of the two cohorts: hip replacements and knee replacements.
| Group | Gender | Age (years) | |
|---|---|---|---|
| Male | Female | ||
| Control group ( | 10 | 13 | 67.54 ± 1.29 |
| Observation group ( | 9 | 14 | 68.27 ± 1.34 |
|
| 15.235 | 20.685 | 8.43 |
|
| 0.96 | 0.93 | 0.82 |
Comparison of the incidence of deep venous thrombosis between the groups.
| Group | Incidence of deep venous thrombosis ( |
|---|---|
| Control group ( | 8, 34.8 |
| Observation group ( | 2, 8.7 |
|
| 4.511 |
|
| 0.034 |
Functional recovery of the lower limbs.
| Group | Straight leg raising time (d) | Walking time (d) | Vertical knee flexion time (d) |
|---|---|---|---|
| Control group ( | 1.76 ± 0.51 | 2.48 ± 0.67 | 2.19 ± 0.55 |
| Observation group ( | 1.34 ± 0.21 | 2.03 ± 0.55 | 1.68 ± 0.38 |
|
| 3.807 | 2.596 | 3.814 |
|
| <0.01 | 0.013 | <0.01 |
Assessment of joint function, pain, and quality of life.
| Group | Harris score | VAS pain score | Life quality score | Range of motion (ROM) |
|---|---|---|---|---|
| Control group ( | 80.11 ± 8.42 | 1.51 ± 0.32 | 71.22 ± 5.12 | 101.21 ± 8.42 |
| Observation group ( | 88.12 ± 10.32 | 1.11 ± 0.25 | 79.22 ± 6.25 | 108.12 ± 10.33 |
|
| 4.253 | 6.965 | 6.914 | 3.667 |
|
| <0.01 | <0.01 | <0.01 | <0.01 |
Serum D-dimer, FDP and Peak values of femoral vein blood flow.
| Group | serum D-dimer (mg/L) | FDP (ug/L) | Peak blood flow of common femoral vein (cm/s) |
|---|---|---|---|
| Control group ( | 0.34 ± 0.09 | 11.6 ± 2.4 | 19 ± 4 |
| Observation group ( | 0.29 ± 0.09 | 10.5 ± 2.1 | 21 ± 4 |
|
| 5.364 | 7.076 | 7.025 |
|
| <0.01 | <0.01 | <0.01 |
Self-rating anxiety scale (SAS) and self-rating depression scale (SDS).
| Group | SAS | SDS |
|---|---|---|
| Control group ( | 54 ± 3.1 | 53 ± 2.4 |
| Observation group ( | 42 ± 1.3 | 40 ± 1.7 |
|
| 47.218 | 46.312 |
|
| <0.01 | <0.01 |